Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2026 · 56 positions · Total reported value $1.88B · Top-10 concentration 59.2% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Sofinnova Investments, Inc. disclosed 56 equity positions with a combined reported value of $1.88B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were NTRA ($420.82M), VERA ($119.89M), GMAB ($111.12M). By sector, the heaviest allocations are Health Care 100.0%. Versus the prior quarter, allocation shifted toward Health Care (+18.9pp) and away from Other (-18.9pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 52% of names.

The largest new positions opened in Q2 2026 were SPTX ($77.43M), GILD ($43.35M), ISRG ($15.91M).

Of the 26 positions fully exited versus the prior quarter, the largest were IWM ($148.80M), XBI ($134.12M), AZN ($89.94M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • SPTX SEAPORT THERAPEUTICS INC · $77.43M
  • GILD GILEAD SCIENCES · $43.35M
  • ISRG INTUITIVE SURGICAL INC · $15.91M
  • GMED GLOBUS MED INC CL A · $15.80M
  • NRIX NURIX THERAPEUTICS INC · $12.71M
  • DSGN DESIGN THERAPEUTICS INC · $12.52M
  • TRAX FIRST TRACKS BIOTHERAPEU W/I · $11.37M
  • ABT ABBOTT LABORATORIES · $11.16M

Fully Exited (vs previous quarter)

  • IWM ISHARES RUSSELL · prev qtr: $148.80M
  • XBI STATE STREET SPDR S&P BIOTECH ETF · prev qtr: $134.12M
  • AZN ASTRAZENECA PLC · prev qtr: $89.94M
  • QQQ INVESCO QQQ TR · prev qtr: $86.58M
  • IBB ISHARES BIOTECHNOLOGY ETF · prev qtr: $80.20M
  • BIIB BIOGEN INC COM · prev qtr: $42.08M
  • CELC CELCUITY INC · prev qtr: $34.24M
  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $30.39M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $420.82M 22.42%
22.42%
Hold
2 2.79M $119.89M 6.39%
6.39%
Hold
3 4.05M $111.12M 5.92%
5.92%
Add
4 365.34K $88.04M 4.69%
4.69%
Reduce
5 1.90M $79.36M 4.23%
4.23%
Hold
6 3.56M $77.43M 4.12%
4.12%
New
7 1.70M $58.95M 3.14%
3.14%
Hold
8 2.29M $56.22M 3.00%
3.00%
Hold
9 876.97K $50.53M 2.69%
2.69%
Reduce
10 1.04M $48.20M 2.57%
2.57%
Add
11 408.03K $45.30M 2.41%
2.41%
Reduce
12 343.10K $43.35M 2.31%
2.31%
New
13 76.49K $41.44M 2.21%
2.21%
Reduce
14 1.04M $40.06M 2.13%
2.13%
Reduce
15 160.43K $39.27M 2.09%
2.09%
Reduce
16 3.67M $37.17M 1.98%
1.98%
Add
17 1.66M $36.83M 1.96%
1.96%
Add
18 1.72M $36.45M 1.94%
1.94%
Add
19 925.12K $34.48M 1.84%
1.84%
Reduce
20 493.54K $33.31M 1.77%
1.77%
Add
21 471.76K $32.93M 1.75%
1.75%
Reduce
22 881.30K $30.48M 1.62%
1.62%
Add
23 945.69K $29.16M 1.55%
1.55%
Add
24 303.10K $28.72M 1.53%
1.53%
Reduce
25 358.57K $20.52M 1.09%
1.09%
Reduce
26 148.99K $18.32M 0.98%
0.98%
Add
27 255.82K $17.17M 0.92%
0.92%
Reduce
28 158.40K $16.89M 0.90%
0.90%
Reduce
29 500.00K $16.70M 0.89%
0.89%
Add
30 40.00K $15.91M 0.85%
0.85%
New
31 200.00K $15.80M 0.84%
0.84%
New
32 380.92K $15.48M 0.82%
0.82%
Reduce
33 254.20K $13.83M 0.74%
0.74%
Add
34 524.10K $12.71M 0.68%
0.68%
New
35 865.13K $12.52M 0.67%
0.67%
New
36 255.90K $12.04M 0.64%
0.64%
Reduce
37 565.20K $11.37M 0.61%
0.61%
New
38 123.00K $11.16M 0.59%
0.59%
New
39 146.24K $10.70M 0.57%
0.57%
Add
40 500.04K $7.28M 0.39%
0.39%
Add
41 144.43K $6.35M 0.34%
0.34%
New
42 337.40K $3.91M 0.21%
0.21%
New
43 27.59K $3.23M 0.17%
0.17%
Hold
44 107.39K $2.39M 0.13%
0.13%
Hold
45 364.76K $2.25M 0.12%
0.12%
Hold
46 6.44K $2.16M 0.12%
0.12%
Reduce
47 47.51K $1.59M 0.09%
0.09%
Hold
48 321.69K $1.47M 0.08%
0.08%
Add
49 166.67K $1.29M 0.07%
0.07%
New
50 189.25K $1.10M 0.06%
0.06%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 40% R 40% F1 40% (modelled on 2026-Q1; 4/10 hit)

Low-confidence forecast This fund replaces about 48% of its Top-10 each quarter and backtests at F1 49% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 49% · recall 49% · F1 49% · avg rank error 3.5 · Top-10 turnover 48%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% KRTX · RYZB · MRK · ASND · NTRA · AVTE · IDYA · VERA · AZN · IMGN NTRA · VERA · ASND · AVTE · MRK · XBI · NVO · INCY · ARGX · ISRG
2024-Q2 50% 50% 50% NTRA · VERA · ASND · AVTE · MRK · INCY · XBI · NVO · ARGX · DYN QQQ · NTRA · VERA · ASND · NVO · SYK · AZN · DYN · ALGN · EW
2024-Q3 40% 40% 40% QQQ · NTRA · ASND · VERA · NVO · SYK · AZN · DYN · ALGN · SNDX NTRA · VERA · NVO · AZN · IDYA · ELAN · BIOA · INCY · RAPP · AVBP
2024-Q4 40% 40% 40% NTRA · VERA · NVO · AZN · IDYA · ELAN · INCY · BIOA · RAPP · AVBP NTRA · VERA · GILD · ABBV · JAZZ · SRPT · AVBP · AZN · SYK · REPL
2025-Q1 50% 50% 50% NTRA · VERA · GILD · JAZZ · ABBV · SRPT · SYK · AVBP · REPL · AZN NTRA · SYK · QQQ · IWM · VERA · JAZZ · MDT · ALNY · GILD · LLY
2025-Q2 50% 50% 50% NTRA · SYK · QQQ · IWM · JAZZ · VERA · ALNY · MDT · LLY · IDYA NTRA · GILD · LLY · JAZZ · VERA · IWM · ABBV · IBB · BSX · DXCM
2025-Q3 60% 60% 60% NTRA · GILD · LLY · JAZZ · VERA · IWM · BSX · IDYA · DXCM · BBIO NTRA · GILD · VERA · JAZZ · AZN · RAPP · BSX · DXCM · ISRG · AXSM
2025-Q4 50% 50% 50% NTRA · GILD · VERA · JAZZ · AZN · BSX · RAPP · DXCM · ISRG · AXSM NTRA · JAZZ · AZN · VERA · BMY · UTHR · VRTX · ABBV · ISRG · COGT
2026-Q1 60% 60% 60% NTRA · JAZZ · AZN · VERA · BMY · VRTX · UTHR · ISRG · COGT · ABBV NTRA · IWM · XBI · BMY · JAZZ · VERA · AZN · QQQ · COGT · IBB
2026-Q2 ★ 40% 40% 40% NTRA · IWM · XBI · BMY · JAZZ · VERA · AZN · IBB · COGT · QQQ NTRA · VERA · GMAB · JAZZ · RAPP · SPTX · AVBP · BIOA · BMY · SUPN

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Sofinnova Investments, Inc. buy in 2026-Q2?

In its 2026-Q2 13F filing, Sofinnova Investments, Inc. reported 56 equity positions worth $1.88B in aggregate; its largest disclosed positions were NTRA ($420.82M), VERA ($119.89M), GMAB ($111.12M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $1.88B of long equity holdings across 56 positions as of 2026-Q2. Top-10 holdings account for 59.2% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →